Filing Details
- Accession Number:
- 0001209191-21-014547
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-25 21:02:54
- Reporting Period:
- 2021-02-23
- Accepted Time:
- 2021-02-25 21:02:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1346830 | Cara Therapeutics Inc. | CARA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1166287 | T Derek Chalmers | C/O Cara Therapeutics, Inc. 4 Stamford Plaza, 107 Elm St, 9Th Floor Stamford CT 06902 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-02-23 | 18,750 | $0.00 | 955,343 | No | 4 | A | Direct | |
Common Stock | Disposition | 2021-02-25 | 11,729 | $19.33 | 943,614 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents the number of shares that vested under a performance-based restricted stock unit award (the "RSU") based on the Issuer's satisfaction of certain performance criteria of the award. In light of the performance-based vesting conditions of the award, such shares were not reportable under Section 16 until vesting was determined, which occurred on February 23, 2021. The vested shares represents the last possible vesting event of the total number of shares subject to the award.
- This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on September 6, 2018 to satisfy the tax withholding obligations triggered by the vesting of RSUs, and does not represent a discretionary trade by the Reporting Person.